Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis
The DOI matches its Crossref record; 94 of the 96 references it cites were found in a registry or an index.
Abstract
The identification of molecular differences in the endometrium of women with endometriosis is an important step toward understanding the pathogenesis of this condition and toward developing novel strategies for the treatment of associated infertility and pain. In this study, we conducted global gene expression analysis of endometrium from women with and without moderate/severe stage endometriosis and compared the gene expression signatures across various phases of the menstrual cycle. The transcriptome analysis revealed molecular dysregulation of the proliferative-to-secretory transition in endometrium of women with endometriosis. Paralleled gene expression analysis of endometrial specimens obtained during the early secretory phase demonstrated a signature of enhanced cellular survival and persistent expression of genes involved in DNA synthesis and cellular mitosis in the setting of endometriosis. Comparative gene expression analysis of progesterone-regulated genes in secretory phase endometrium confirmed the observation of attenuated progesterone response. Additionally, interesting candidate susceptibility genes were identified that may be associated with this disorder, including FOXO1A, MIG6, and CYP26A1. Collectively these findings provide a framework for further investigations on causality and mechanisms underlying attenuated progesterone response in endometrium of women with endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Progesterone resistance has been well-established in both the endometriotic lesions and eutopic endometrium of women with endometriosis [54].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [54]
In the citing paper
“which have demonstrated that the endometrium of endometriosis patients displays aberrant molecular expression patterns that give it the ability to implant, invade, and develop into endometriotic foci (27)(28)(29)(30).”
From Biomarkers in endometriosis: Challenges and opportunities (2017) · cites this paper as [27]
In the citing paper
“Burney et al., based on their previous transcriptomics analysis (27) and with the use of computational analysis, discovered a potential functional relationship between decreased expression of miR-9 and miR-34 families in early secretoryphase eutopic endometrium of patients and their role in the delayed transition from proliferative to secretory phase in women with severe endometriosis (85).”
From Biomarkers in endometriosis: Challenges and opportunities (2017) · cites this paper as [27]
In the citing paper
“At the transcript level, significant differences in gene expression exist in eutopic endometrium from women with versus without endometriosis [114–117].”
From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [115]
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Self-citationSampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356 · cited 1×
“assays in response to progesterone and cAMP (39).”
BackgroundNoyes, R. W., Hertig, A. T., & Rock, J. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33500-1 · Cited by 941
Effect of endometriosis on in vitro fertilization
Barnhart, K., Dunsmoor-Su, R., & Coutifaris, C. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03112-6 · Cited by 794
Kao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A., & Giudice, L. C. (2003) · Endocrinology · doi:10.1210/en.2003-0043 · Cited by 696 · cited 10×
“3822 Endocrinology, August 2007, 148(8):3814–3826 Burney et al.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Usadi, 2003, The effects of low luteal phase progesterone concentrations on the histologic and functional characteristics of the endometrium, J Soc Gynecol Investig, 10, 386A
Cited by
Items 401–500 of 786
A cross-study gene set enrichment analysis identifies critical pathways in endometriosis
Zhao, H., Wang, Q., Bai, C., He, K., & Pan, Y. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-94 · Cited by 23
Ekine, A. A., Fülöp, I., István, T., Árpád, R., Jeges, S., Koppán, Á., & Koppán, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020507 · Cited by 22
Pavličev, M., McDonough-Goldstein, C. E., Zupan, A. M., Muglia, L. M., Hu, Y., Kong, F., Monangi, N., Dagdas, G., Župančič, N., Maziarz, J. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45338-4 · Cited by 22
“…incomplete transition of the endometrium from the estrogen-dominated proliferative phase to the progesterone-dominated secretoryphaseof the estrous cycle, also referred to as progesterone resistance 15 , due to dysregulation in the early secretory phase of many genes mediating progesterone effects.”
Kobayashi, H., Uekuri, C., & Shigetomi, H. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.831832 · Cited by 22
“Down-regulation of transcription factors FOXO1 (forkhead box O1) [6,26,27] and HOXA10 (homeobox A10) [12,28] may contribute to the reduced expression of IGFBP-1 (insulin-like”
BackgroundInfluentialEmbryo quality before and after surgical treatment of endometriosis in infertile patients
Shahine, L. K., Burney, R. O., Behr, B. R., Milki, A. A., Westphal, L. M., & Lathi, R. B. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-008-9287-1 · Cited by 22
“Endometrium from women with endometriosis seems to have decreased expression of integrin [16] and HOXA10 [17], alterations in apoptosis [18], and a gene expression profile consistent with progesterone resistance [19].”
BackgroundSelf-citationChoi, J., Jo, M., Lee, E., Lee, D., & Choi, D. (2019) · Molecular Human Reproduction · doi:10.1093/molehr/gaz064 · Cited by 23
Prašnikar, E., Knez, J., Kovačič, B., & Kunej, T. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01833-3 · Cited by 22
“Repeated genes associated with P-phase (ACTB, ANXA4, BPIFB1, EPHX1,MUC5B, PRDX2, and VIM) could indicate stronger genetic causes associated with pathophysiology of endometriosis.”
BackgroundInfluentialChoi, J., Jo, M., Lee, E., Kim, S. E., Lee, D., & Choi, D. (2022) · Molecular Human Reproduction · doi:10.1093/molehr/gaac007 · Cited by 22
Shen, F., Yan, C.-Y., Liu, M., Feng, Y.-H., & Chen, Y. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3419-x · Cited by 22
Oestrogen, progesterone and stem cells: the discordant trio in endometriosis?
S, C. J., Pillai, S. M., & Nair, S. A. (2018) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.13 · Cited by 21
Hughes, S. M., Pandey, U., Johnston, C., Marrazzo, J. M., Hladik, F., & Micks, E. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13412 · Cited by 21
Iwase, A., Kotani, T., Goto, M., Kobayashi, H., Takikawa, S., Nakahara, T., Nakamura, T., Kondo, M., Bayasula, Nagatomo, Y., et al. (2013) · Reproductive Sciences · doi:10.1177/1933719113488449 · Cited by 21
Surrey, E. S., Lietz, A. K., Gustofson, R. L., Minjarez, D. A., & Schoolcraft, W. B. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.023 · Cited by 21
The Human Endometrium-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling
Zieba, A., Sjöstedt, E., Olovsson, M. H., Fagerberg, L., Hallström, B. M., Oskarsson, L., Edlund, K., Tolf, A., Uhlén, M., & Pontén, F. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0115 · Cited by 21
“2 Science for Life Laboratory, KTH—Royal Institute of Technology, Stockholm, Sweden. et al. 2013), endometriosis (Rahmioglu et al., 2012), and endometrial cancer (Burney et al., 2007; Carson et al., 2002; Smid-Koopman et al., 2000).”
Unexplained recurrent pregnancy loss and unexplained infertility: twins in disguise
Fox, C. W., Savaris, R. F., Jeong, J., Kim, T. H., Miller, P. B. W., Likes, C. E., Schammel, D. P., Young, S. L., & Lessey, B. A. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoz021 · Cited by 21
“Endometriosis has been linked to the genesis of endometrial progesterone resistance (Bulun et al., 2006; Burney et al., 2007; Aghajanova et al., 2010; Joshi et al., 2017) and”
BackgroundSelf-citationIdentifying and optimizing human endometrial gene expression signatures for endometrial dating
Díaz-Gimeno, P., Sebastián-León, P., Sánchez-Reyes, J. M., Späth, K., Alemán, A., Vidal, C., Devesa-Peiró, A., Labarta, E., Ribas, I. S., Ferrando, M., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab262 · Cited by 21
The role of endoplasmic reticulum stress in endometriosis
Al‐Hetty, H. R. A. K., Jabbar, A. D., Eremin, V. F., Jabbar, A. M., Jalil, A. T., Al-Dulimi, A. G., Gharban, H. A. J., Khan, M. U., & Saleh, M. M. (2023) · Cell Stress and Chaperones · doi:10.1007/s12192-023-01323-2 · Cited by 21
“While endometriosis cells are resistant to progesterone-induced apoptosis, they cannot further resist against dienogest, and therefore, currently dienogest is the first-line treatment for endometriosis (Liu et al. 2021; Burney et al. 2007).”
BackgroundSzczepańska, M., Mostowska, A., Wirstlein, P. K., Lianeri, M., Marianowski, P., Skrzypczak, J., & Jagodziński, P. P. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.02.003 · Cited by 21
“The analysis of the transcriptome profile during the window of implantation in healthy women and women with endometriosis has demonstrated the defective expression of many genes regulated by progesterone [28,29] in the women with endometriosis.”
BackgroundEndométriose et génétique : les gènes sont-ils responsables de la maladie ?
Borghese, B., Vaiman, D., de Ziegler, D., & Chapron, C. (2010) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2010.03.006 · Cited by 21
“[90] Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, et al.”
BackgroundInsights from genomic studies on the role of sex steroids in the aetiology of endometriosis
Saunders, P. T. K. (2022) · Reproduction and Fertility · doi:10.1530/raf-21-0078 · Cited by 20
Braga, D. P. A. F., Setti, A. S., Turco, E. G. L., Cordeiro, F. B., Cabral, E. C., Cortezzi, S. S., Ono, É., Figueira, R. C. S., Eberlin, M. N., & Borges, E. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0800-7 · Cited by 20
“Comparison of proteomic data with published gene expression data in similar cohorts of women [47, 49, 50] also have revealed an overall lack of correlation between the two, suggesting that posttranscriptional or translational regulation is an important feature in human biology.”
BackgroundKato, N., Iwase, A., Ishida, C., Nagai, T., Mori, M., Bayasula, Nakamura, T., Osuka, S., Ganiyeva, U., Qin, Y., et al. (2019) · Reproductive Sciences · doi:10.1177/1933719118802053 · Cited by 20
“There are several research demonstrating that progesterone resistance can be seen in eutopic endometrium of women with endometriosis to some extent.(6,8) In this point, further experiments will be required to reveal how and when downregulation of HAND2 in endometriotic cells occurs.”
BackgroundGeethadevi, A., Sharma, J. B., Roy, K. K., Sengupta, J., & Ghosh, D. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0553-0 · Cited by 20
“CE Control endometrium, DIE Deep infiltrating eutopic and ectopic tissues, HPLC High performance liquid chromatography, IHC Im qRTPCR quantitative reverse transcriptase polymerase chain reaction, RV Rectovagin has been reported to be associated with endometriosis [10, 11].”
BackgroundDetermining the Molecular Background of Endometrial Receptivity in Adenomyosis
Prašnikar, E., Kunej, T., Repnik, K., Potočnik, U., Knez, J., & Kovačič, B. (2020) · Biomolecules · doi:10.3390/biom10091311 · Cited by 20
Suleiman, A. A., Nader, A. M., Winzenborg, I., Beck, D., Polepally, A. R., Ng, J., Noertersheuser, P. A., & Mostafa, N. M. (2020) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12560 · Cited by 20
“Progestins are an effective treatment for endometriosis-associated pain, but patients receiving progestin therapy may experience undesirable side effects, such as weight gain, mood changes, and irregular bleeding.(1,3,4) GnRH agonists are also effective for managing pain associated with endometriosis; however, these a…”
BackgroundPaolo, A. D., Vignini, A., Alia, S., Membrino, V., Carpini, G. D., Giannella, L., & Ciavattini, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113538 · Cited by 20
“In the luteal phase, a dysregulation of progesterone responsive genesis is noticeable when analyzing endometrial expression [39,40].”
BackgroundGower, A. C., Spira, A. E., & Lenburg, M. E. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-381 · Cited by 20
“In series GSE6364 [23] and GSE4888 [24], samples obtained during the proliferative phase of the menstrual cycle had significantly higher SA scores than those obtained during the mid secretory phase. openSESAME identifies experiments related to stratified squamous epithelia in GEO using a signature…”
MethodLi, B., Wang, S., Duan, H., Wang, Y., & Guo, Z. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.10.005 · Cited by 20
Lin, A., Yin, J. J., Cheng, C., Yang, Z., & Yang, H. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.11.001 · Cited by 19
Poor Endometrial Proliferation After Clomiphene is Associated With Altered Estrogen Action
Bressler, L. H., Fritz, M. A., Wu, S., Yuan, L., Kafer, S., Wang, T., DeMayo, F. J., & Young, S. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab381 · Cited by 19
Bulun, S. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00025-1 · Cited by 19
Innovations in classical hormonal targets for endometriosis
Pluchino, N., Freschi, L., Wenger, J., & Streuli, I. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1129895 · Cited by 19
“progesterone-induced paracrine factors that stimulate HSD17B2 may be due to the very low levels of PR observed in vivo in endometriotic tissue.[21]”
BackgroundVargas, E., Aghajanova, L., Gemzell‐Danielsson, K., Altmäe, S., & Esteban, F. J. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.11.003 · Cited by 19
Inside the granulosa transcriptome
D’Aurora, M., Sperduti, S., Emidio, G. D., Stuppia, L., Artini, P. G., & Gatta, V. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1223288 · Cited by 19
“authors investigated the expression in GCs of progesterone receptors (PRs), estrogen receptor (ER) and enzymes involved in hormone productions [54,55].”
BackgroundPathophysiology of Infertility in Endometriosis
Lessey, B. A., & Young, S. L. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch23 · Cited by 18
Self-citationMolecular Basis of Impaired Decidualization in the Eutopic Endometrium of Endometriosis Patients
Retis-Resendiz, A. M., Gómez-Suárez, S. K., García-Gómez, E., & Vázquez-Martínez, E. R. (2025) · Cells · doi:10.3390/cells14050326 · Cited by 18
“Impaired decidualization has been mainly associated with P4 resistance in endometriotic lesions of endometriosis patients [15,16].”
Kibanov, M. V., Makhmudova, G. M., & Gokhberg, Y. A. (2019) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2019-47-005 · Cited by 18
Arosh, J. A., Lee, J., & Banu, S. K. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111446 · Cited by 18
Rossi, M., Seidita, I., Vannuccini, S., Prisinzano, M., Donati, C., & Petraglia, F. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.01.007 · Cited by 18
Heard, M. E., Velarde, M. C., Giudice, L. C., Simmen, F. A., & Simmen, R. C. M. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.130260 · Cited by 18
“Moreover, in ectopic lesions the preferential loss of PGR-B relative to PGR-A, resulting in a higher PGR-A:PGR-B expression ratio, has been observed [8–10].”
BackgroundResultSelf-citationEffects of noncavity-distorting fibroids on endometrial gene expression and function†
Aghajanova, L., Houshdaran, S., Irwin, J. C., & Giudice, L. C. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox107 · Cited by 18
“These results suggest that at the global transcriptome level, endometrium from subjects with fibroid uteri is different from control subjects with no uterine pathology, similar to reports on adenomyosis and endometriosis [30,31].”
Self-citationChemosensitivity and chemoresistance in endometriosis – differences for ectopic versus eutopic cells
Lavõgina, D., Samuel, K., Lavrits, A., Meltsov, A., Sõritsa, D., Kadastik, Ü., Peters, M., Rinken, A., & Salumets, A. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.05.019 · Cited by 18
Pezzuto, A., Pomini, P., Steinkasserer, M., Nardelli, G. B., & Minelli, L. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.08.007 · Cited by 18
“Emerging evidence suggests that endometriosis is associated with progesterone resistance characterized by suboptimal expression of target genes [10].”
BackgroundCattenoz, P. B., Delaporte, C., Bazzi, W., & Giangrande, A. (2016) · Scientific Reports · doi:10.1038/srep37792 · Cited by 17
Detailed review paper on the Retinoid System
OECD (2021) · OECD series on testing and assessment · doi:10.1787/4fbb70a9-en · Cited by 17
Korzekwa, A. J., Bah, M. M., Gęstwicka, M., Socha, B. M., & Skarzynski, D. J. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2012.09.023 · Cited by 17
“However, with regard to the etiopathology of adenomyosis, disturbances in the E2–P4 equilibrium, related to changes in secretion and activity in the reproductive tract, seem to play a fundamental role [1,8,13].”
BackgroundLee, S. Y., Lee, Y. Y., Choi, J. S., Yoon, M., & Han, J. (2016) · FEBS Journal · doi:10.1111/febs.13914 · Cited by 17
Endometriosis and the menopause: why the question merits our full attention
Lydia, M.-S., Even, M., de Jolinière, J. B., & Ayoubi, J.-M. (2019) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0071 · Cited by 17
Wang, L., Xing, Q., Feng, T., He, M., Yu, W., & Chen, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29406 · Cited by 17
“Overproduction of estrogen and cytokines, progesterone resistance, and epigenetic deregulation of gene expression in endometriotic tissues have been recently investigated as possible contributors of endometriosis.(1,2) Unlike other noncoding RNAs (ncRNAs) with known functions, such as small nuclear RNAs (snRNAs) for R…”
BackgroundMcAllister, S. L., Sinharoy, P., Vasu, M., & Gross, E. R. (2020) · Pain · doi:10.1097/j.pain.0000000000001949 · Cited by 17
Broi, M. G. D., Rocha, C. V., Meola, J., Martins, W. P., Carvalho, F. M., Ferriani, R. A., & Navarro, P. A. (2017) · JBRA · doi:10.5935/1518-0557.20170038 · Cited by 17
“Nevertheless, there is evidence that infertile women with endometriosis are partially resistant to progesterone (Burney et al., 2007; Bulun, 2010), which may be due to an abnormal progesterone signaling as a result of aberrant expression of its receptors (Bedaiwy et al., 2015).”
BackgroundInfluentialBiomarker development in endometriosis
Burney, R. O. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936692 · Cited by 16
Self-citationZheng, W., Xiang, D., Wen, D., Luo, M., Liang, X., & Cao, L. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154404 · Cited by 16
MCP-1 exerts the inflammatory response via ILK activation during endometriosis pathogenesis
Soni, U. K., Tripathi, R., & Jha, R. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122902 · Cited by 16
Golinska, M. A., Rycerz, A., Sobczak, M., Chrzanowski, J., Stawiski, K., & Fendler, W. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619434 · Cited by 16
Blockeel, C., Vaerenbergh, I. V., Fatemi, H. M., Lommel, L. V., Devroey, P., & Bourgain, C. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq070 · Cited by 16
“, 2008) and ALDH1A3 (Burney et al., 2007; Macklon et al., 2008).”
Patiño-García, D., Palomino, J., Pomés, C., Celle, C., Torres-Estay, V. A., & Orellana, R. (2023) · Biomedicines · doi:10.3390/biomedicines11041169 · Cited by 16
“Synthetic versions of P4 (progestins) represent a safe option by reducing E2 levels [28] through its inactivation to estrone [29], and induce direct anti-proliferative and anti-inflammatory effects [30].”
BackgroundZipponi, M., Cacciottola, L., & Dolmans, M. (2024) · Human Reproduction · doi:10.1093/humrep/deae116 · Cited by 16
Identification of key genes and pathways in endometriosis by integrated expression profiles analysis
Cui, D., Liu, Y., Ma, J., Lin, K., Xu, K., & Lin, J. (2020) · PeerJ · doi:10.7717/peerj.10171 · Cited by 16
“, 2007), GSE6364 contains datasets of 21 EUand 16NE samples (Burney et al., 2007), and GSE4888 contains datasets of 27 NE samples (Talbi et al.”
BackgroundSyrcle, S. M., Pelch, K. E., Schroder, A. L., Nichols, B. M., Mills, M. P., Barrier, B. F., Havey, A. D., & Nagel, S. C. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000320736 · Cited by 16
“Estrogens are known to stimulate endometrial cell proliferation. In the current study, we found increased proliferation in the vaginal polyp stroma relative to control vaginal tissue consistent with estrogen-regulated cell proliferation. This is despite the patient’s use of the long-acting progestin, Depo-Provera, whi…”
BackgroundZhao, L., Yang, H., Yu, X., Luo, Z., Lin, Q., Zhao, J., Ren, N., Zhou, S., & Zhao, X. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.11.013 · Cited by 16
“Three GEO datasets analyzing endometriosis were identified, including GSE5108, GSE6364, and GSE7305 [6–8].”
MethodLuteal phase HCG support for unexplained recurrent pregnancy loss – a low hanging fruit?
Fox, C. W., Azores-Gococo, D., Swart, L., Holoch, K., Savaris, R. F., Likes, C. E., Miller, P. B. W., Forstein, D. A., & Lessey, B. A. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.11.016 · Cited by 16
Self-citationMicroanatomy and function of the eutopic endometrium in women with endometriosis
Al‐Jefout, M., Tokushige, N., Hey‐Cunningham, A. J., Manconi, F., Ng, C. H. M., Schulke, L., Berbic, M., Markham, R., & Is, F. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.1.61 · Cited by 16
Retinoids in Mammalian Reproduction, with an Initial Scoping Effort to Identify Regulatory Methods
Nilsson, C. B. (2020) · TemaNord · doi:10.6027/temanord2020-507 · Cited by 15
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health
Khan, S., Syeda, S., Raghuvanshi, Y., & Shrivastava, A. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09975-4 · Cited by 15
Choi, J., Jo, M., Lee, E., Lee, D., & Choi, D. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab002 · Cited by 15
Popovic, M., & Lopes, S. M. C. D. S. (2022) · Placenta · doi:10.1016/j.placenta.2022.01.006 · Cited by 15
Loss of KLF15 impairs endometrial receptivity by inhibiting EMT in endometriosis
Huang, Y., Wang, Z., Li, B., Ke, L., Xiong, Y., & Zhang, Y. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0319 · Cited by 15
Xu, W. D., Zhu, S., Zhou, Y., Jin, Y., Dai, H., & Wang, X. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.52 · Cited by 15
Poli‐Neto, O. B., Carlos, D., Favaretto, A. L., Silva, J. C. R. E., Meola, J., & Tiezzi, D. G. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103307 · Cited by 15
Reproductomics: Exploring the Applications and Advancements of Computational Tools
Sengupta, P., Dutta, S., Liew, F. F., Samrot, A. V., Dasgupta, S., Rajput, M., Sláma, P., Kolesárová, A., & Roychoudhury, S. (2024) · Physiological Research · doi:10.33549/physiolres.935389 · Cited by 14
Ciavattini, A., Carpini, G. D., Serri, M., Tozzi, A., Leoni, F., Loreto, E. D., & Saccucci, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9256 · Cited by 14
“It is well known that UPR is constitutively active in cells with secretory functions and subjected to hormonal stimulation, such as endometrial cells (32-35).”
Analyzing biomarker discovery: Estimating the reproducibility of biomarker sets
Forouzandeh, A., Rutar, A., Kalmady, S., & Greiner, R. (2021) · bioRxiv · doi:10.1371/journal.pone.0252697 · Cited by 13
“71 GDS2737 [65] 37 (57%) 54675 4 0 ± 0 10.”
Huang, Y., Li, Q., Hu, R. M., Li, R., & Yang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011742 · Cited by 14
Characterizing the Extracellular Matrix Transcriptome of Endometriosis
Cook, C. J., Wiggin, N., & Fogg, K. C. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01359-w · Cited by 14
“…Omnibus (GEO) database (http:// ncbi. nlm. nih. gov/ geo/) was accessed to retrieve four datasets using the same search criteria, and subsequent filtration methods, as Poli-Neto et al. [4] The four datasets which were retrieved were from GSE4888 [13], GSE6364 [14], GSE7305 [15], and GSE51981 [16].”
MethodPei, F., Jia, J., Lin, S., Chen, X., Wu, L., Lin, Z.-X., Sun, B.-W., & Zeng, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1298457 · Cited by 14
Mig-6 Mouse Model of Endometrial Cancer
Kim, T. H., Yoo, J., & Jeong, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_8 · Cited by 14
MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT
Yoo, J., Kang, H., Broaddus, R. R., Risinger, J. I., Choi, K.-C., & Kim, T. H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4502-7 · Cited by 14
Mazur, E. C., Large, M. J., & DeMayo, F. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00024-7 · Cited by 14
A current view of the role of epigenetic changes in the aetiopathogenesis of endometriosis
Kokcu, A. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2015.1036403 · Cited by 13
“In the last decade, numerous large-scale gene expression profiling studies have demonstrated, unequivocally, that many genes are deregulated in endometriosis (Burney et al. 2007; Flores et al. 2007; Pelch et al. 2010; Mettler et al. 2007; Umezawa et al. 2009; Wu et al. 2006; Zafrakas et al. 2008).”
BackgroundLi, R., Tran, D. N., Lessey, B. A., Young, S. L., Kim, T. H., & Jeong, J. (2024) · F&S Science · doi:10.1016/j.xfss.2024.02.001 · Cited by 13
Self-citationTreatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
Taylor, H. S., Giudice, L. C., Lessey, B. A., Ms, A., Kotarski, J., Df, A., Diamond, M. P., Surrey, E. S., Np, J., Nb, W., et al. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.15.6 · Cited by 13
Self-citationLiu, Y., Fan, L., Jin, L., Lu, C., Li, T., Zhang, Z., Xie, C., Li, S., Zhang, Y., Ren, J. M., et al. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14430 · Cited by 13
Kai, K., Joshi, N., Burns, G. W., Hrbek, S. M., Vegter, E. L., Ochoa-Bernal, M. A., Song, Y., Moldovan, G. E., Sempere, L. F., Miyadahira, E. H., et al. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01253-5 · Cited by 13
“Additionally, the profile and role of miR-210 and its downstream targets during the secretory phase have yet to be determined, even though gene alterations related to progesterone resistance that reduces endometrial receptivity and causes implantation failure in women with endometriosis have been mostly observed durin…”
BackgroundLiu, H., Franken, A., Bielfeld, A. P., Fehm, T. N., Niederacher, D., Cheng, Z., Neubauer, H. J., & Stamm, N. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01188-9 · Cited by 13
“Samples from different menstruation phases (proliferative/PE, early secretory/ESE, mid-secretory/MSE, late secretory/LES) were chosen from GSE4888 and GSE56364 to detect expression of PGRMC1 [21, 22].”
MethodShen, Y., Liu, H.-J., Sun, L., Niu, X., Kuang, X., Wang, P., Sheng, H., & Huang, W. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0021-1 · Cited by 13
“It also involved in directing the differentiation process [16, 22, 23].”
SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis
Piccinato, C. D. A., Malvezzi, H., Gibson, D. A., & Saunders, P. T. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0297 · Cited by 13
Zhou, Y., Lin, L., Chen, Z., Wang, Y., Chen, C., Li, E., & Wu, R. (2019) · Medicine · doi:10.1097/md.0000000000016965 · Cited by 13
“First, the eutopic endometrium is resistant to the selective actions of progesterone that affect downstream P target genes and ultimately leads to decidualization [13] ; Second, the detrimental effects of the inflammatory process related to endometriosis can impede the progression of early embryos during the first tri…”
BackgroundLuque-Córdoba, D., López-Bascón, M. A., & Priego‐Capote, F. (2020) · Talanta · doi:10.1016/j.talanta.2020.121415 · Cited by 13
Wei, J., Huang, B., Nong, Y., Zhang, Q., Liu, W., Xie, Y., Peng, T., Wang, W., Liang, X., Li, Q., et al. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01130-7 · Cited by 13
“Array GSE6364 GPL570 [HG-U133_Plus_2] 5 6 Burney et al.[20]”
Giudice, L. C., Swiersz, L. M., & Burney, R. O. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00130-1 · Cited by 13
Self-citationTaylor, R. N., & Lebovic, D. I. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00024-3 · Cited by 14
Circulating Endometrial Cells in Women with Spontaneous Pneumothorax
Kiss, I., Pospisilova, E., Kolostova, K., Maly, V., Stanek, I., Lischke, R., Schutzner, J., Pawlak, I., & Bobek, V. (2020) · Chest · doi:10.1016/j.chest.2019.09.008 · Cited by 12
MicroRNAs and the pathogenesis of endometriosis
Neubauer, C., Kiesel, L., & Götte, M. (2012) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.2012.9226 · Cited by 12
Kamergorodsky, G., Invitti, A. L., D’Amora, P., Parreira, R. M., Kopelman, A., Bonetti, T. C., Girão, M. J. B. C., & Schor, E. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110743 · Cited by 12
Erikson, D. W., Chen, J. C., Piltonen, T., Conti, M., Irwin, J. C., & Giudice, L. C. (2014) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000198 · Cited by 12
Self-citationXenografted tissue models for the study of human endometrial biology
Kuokkanen, S., Zhu, L., & Pollard, J. W. (2017) · Differentiation · doi:10.1016/j.diff.2017.11.004 · Cited by 12
“Inadequate exposure or reduced responsiveness of the endometrium to P additionally exacerbates the development of endometrial pathology, including endometrial hyperplasia and adenocarcinoma as well as endometriosis that are driven by E2 (Burney et al., 2007).”
Using advanced spatial and single-cell transcriptomics to characterize the human endometrium
Wang, X., & Hawkins, S. M. (2021) · Nature Genetics · doi:10.1038/s41588-021-00982-0 · Cited by 12
Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023
Vallée, A., Sarıdoğan, E., Petraglia, F., Keckstein, J., Polyzos, N. P., Wyns, C., Gianaroli, L., Tarlatzis, B. C., Ayoubi, J. M., & Féki, A. (2024) · Facts Views and Vision in ObGyn · doi:10.52054/fvvo.16.s1.011 · Cited by 11
Lu, F.-F., Wang, Z., Yang, Q., Yan, F.-S., Xu, C., Wang, M.-T., Xu, Z.-J., Cai, S.-Y., & Guan, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1438079 · Cited by 11
Metadata
- Authors
- Burney, R. O., Talbi, S., Hamilton, A. E., Vo, K. C., Nyegaard, M., Nezhat, C. R., Lessey, B. A., & Giudice, L. C.
- Affiliations
- Stanford Medicine (US)
- Department of Obstetrics, Gynecology, and Reproductive Sciences (S.T., A.E.H., K.C.V., L.C.G.), University of California, San Francisco, San Francisco, California 94143-0138
- University of California, San Francisco (US)
- Prisma Health (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 148
- Issue
- 8
- Pages
- 3814-3826
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2052734212
- Cited by
- 735
- References
- 96
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 40 · 2023: 45 · 2022: 37 · 2021: 42 · 2020: 45 · 2019: 39 · 2018: 38 · 2017: 39 · 2016: 46 · 2015: 36 · 2014: 35 · 2013: 46 · 2012: 39
- FWCI
- 37.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD035041, U54 HD-31398-09, U54HD031398, HD35041)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- endometriosis, endometrium, gene expression, progesterone resistance, menstrual cycle, luteal phase, candidate susceptibility genes, FOXO1, MIG6, CYP26A1, DNA synthesis, mitosis, cell survival, infertility
- MeSH terms
- Forkhead Box Protein O1, Retinoic Acid 4-Hydroxylase, Adult, Cytochrome P-450 Enzyme System, Endometriosis, Endometrium, Female, Humans, Leiomyoma, Genetic Linkage, Progesterone, Uterine Neoplasms, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.